Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Lynparza (olaparib). Show all posts
Showing posts with label Lynparza (olaparib). Show all posts
Friday, January 25, 2019

Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer

›
In continuation of my update on  olaparib AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada)  anno...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.